Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Tax Provisions (2019 - 2023)

Historic Tax Provisions for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$100000.0.

  • ADC Therapeutics' Tax Provisions fell 11406.47% to -$100000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$4.3 million, marking a year-over-year decrease of 22994.15%. This contributed to the annual value of -$1139.0 for FY2022, which is 10530.29% down from last year.
  • As of Q3 2023, ADC Therapeutics' Tax Provisions stood at -$100000.0, which was down 11406.47% from -$4.5 million recorded in Q2 2023.
  • ADC Therapeutics' Tax Provisions' 5-year high stood at $1.2 million during Q1 2022, with a 5-year trough of -$4.5 million in Q2 2023.
  • Its 5-year average for Tax Provisions is -$99645.0, with a median of -$268.0 in 2019.
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Tax Provisions showed a top increase of 121940.3% in 2020 and a maximum decrease of 11053829.79% in 2020.
  • Over the past 5 years, ADC Therapeutics' Tax Provisions (Quarter) stood at -$115.0 in 2019, then skyrocketed by 2708.7% to $3000.0 in 2020, then soared by 17015.97% to $513479.0 in 2021, then crashed by 100.77% to -$3967.0 in 2022, then crashed by 2420.8% to -$100000.0 in 2023.
  • Its Tax Provisions stands at -$100000.0 for Q3 2023, versus -$4.5 million for Q2 2023 and $262000.0 for Q1 2023.